Dunne Michael W. 4
4 · Iterum Therapeutics plc · Filed Nov 27, 2023
Insider Transaction Report
Form 4
Dunne Michael W.
Director
Transactions
- Purchase
Ordinary Shares
2023-11-22$2.03/sh+20,000$40,690→ 78,754 total
Footnotes (1)
- [F1]The price reported is a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $1.93 to $2.11. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.